Iparomlimab/Tuvonralimab
QLMA-IIT-CC-001
Phase 2 small_molecule active
Quick answer
Iparomlimab/Tuvonralimab for LOCALLY ADVANCED CERVICAL CANCERS is a Phase 2 program (small_molecule) at Chinese University of Hong Kong with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Chinese University of Hong Kong
- Indication
- LOCALLY ADVANCED CERVICAL CANCERS
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active